• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重心血管风险因素控制在西欧以外地区面临的挑战:来自国际胆固醇管理实践研究的发现。

The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.

机构信息

University of Cape Town, Cape Town, South Africa.

Heart Institute (InCor), University of Sao Paulo Medical School Hospital and Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

出版信息

Eur J Prev Cardiol. 2020 Sep;27(13):1403-1411. doi: 10.1177/2047487319871735. Epub 2019 Sep 19.

DOI:10.1177/2047487319871735
PMID:31533447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7457454/
Abstract

BACKGROUND

Comprehensive control of multiple cardiovascular risk factors reduces cardiovascular risk but is difficult to achieve.

DESIGN

A multinational, cross-sectional, observational study.

METHODS

The International ChoLesterol management Practice Study (ICLPS) investigated achievement of European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guideline low-density lipoprotein cholesterol (LDL-C) targets in patients receiving lipid-modifying therapy in countries outside Western Europe. We examined the rate of, and association between, control of multiple risk factors in ICLPS participants with dyslipidaemia, diabetes and hypertension (N = 2377).

RESULTS

Mean (standard deviation) age of patients was 61.4 (10.4) years; 51.3% were male. Type 2 diabetes was the most common form of diabetes (prevalence, 96.9%). The prevalence of metabolic syndrome was 67.8%, obesity 40.4%, atherosclerotic disease 39.6% and coronary artery disease 33.5%. All patients were at high (38.2%) or very high (61.8%) cardiovascular risk according to ESC/EAS guidelines. Body mass index (BMI) was <25 kg/m in 20.3% of patients, 62.8% had never smoked and 25.2% were former smokers. Overall, 12.2% achieved simultaneous control of LDL-C, diabetes and blood pressure. Risk factor control was similar across all participating countries. The proportion of patients achieving individual guideline-specified treatment targets was 43.9% for LDL-C, 55.5% for blood pressure and 39.3% for diabetes. Multiple correspondence analysis indicated that control of LDL-C, control of blood pressure, control of diabetes, BMI and smoking were associated.

CONCLUSION

Comprehensive control of multiple cardiovascular risk factors in high-risk patients is suboptimal worldwide. Failure to control one risk factor is associated with poor control of other risk factors.

摘要

背景

综合控制多种心血管危险因素可降低心血管风险,但难以实现。

设计

一项多国家、跨地区、观察性研究。

方法

国际胆固醇管理实践研究(ICLPS)调查了在西欧以外国家接受降脂治疗的患者中,欧洲心脏病学会(ESC)/欧洲动脉粥样硬化学会(EAS)指南低密度脂蛋白胆固醇(LDL-C)目标的达标情况。我们检查了患有血脂异常、糖尿病和高血压的 ICLPS 参与者中,多种危险因素控制的比率和相关性(N=2377)。

结果

患者的平均(标准差)年龄为 61.4(10.4)岁;51.3%为男性。2 型糖尿病是最常见的糖尿病类型(患病率为 96.9%)。代谢综合征的患病率为 67.8%,肥胖症为 40.4%,动脉粥样硬化疾病为 39.6%,冠心病为 33.5%。根据 ESC/EAS 指南,所有患者均处于高(38.2%)或极高(61.8%)心血管风险状态。20.3%的患者体重指数(BMI)<25kg/m2,62.8%从未吸烟,25.2%为曾经吸烟者。总体而言,12.2%的患者同时实现了 LDL-C、糖尿病和血压的控制。所有参与国家的危险因素控制情况相似。达到 LDL-C、血压和糖尿病个别指南规定的治疗目标的患者比例分别为 43.9%、55.5%和 39.3%。多元对应分析表明,LDL-C 的控制、血压的控制、糖尿病的控制、BMI 和吸烟与危险因素的控制有关。

结论

在全球范围内,高危患者对多种心血管危险因素的综合控制并不理想。一种危险因素控制不佳与其他危险因素控制不佳相关。

相似文献

1
The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.多重心血管风险因素控制在西欧以外地区面临的挑战:来自国际胆固醇管理实践研究的发现。
Eur J Prev Cardiol. 2020 Sep;27(13):1403-1411. doi: 10.1177/2047487319871735. Epub 2019 Sep 19.
2
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).18 个西欧以外国家的低密度脂蛋白胆固醇目标达标情况:国际胆固醇管理实践研究(ICLPS)。
Eur J Prev Cardiol. 2018 Jul;25(10):1087-1094. doi: 10.1177/2047487318777079. Epub 2018 May 17.
3
Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).南非低密度脂蛋白胆固醇水平的管理:国际胆固醇管理实践研究(ICLPS)
Cardiovasc J Afr. 2019;30(1):15-23. doi: 10.5830/CVJA-2018-054. Epub 2019 Jan 16.
4
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.管理他汀类药物治疗患者与高密度脂蛋白胆固醇和甘油三酯相关的残余心血管疾病风险:临床更新。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9.
5
Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.在西欧以外国家的家族性高胆固醇血症患者中实现低密度脂蛋白胆固醇目标:国际胆固醇管理实践研究。
J Clin Lipidol. 2019 Jul-Aug;13(4):594-600. doi: 10.1016/j.jacl.2019.05.004. Epub 2019 May 14.
6
Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.在高或极高心血管风险患者中他汀类药物的应用和血脂目标达标情况:来自意大利普通实践的见解。
Atherosclerosis. 2018 Apr;271:120-127. doi: 10.1016/j.atherosclerosis.2018.02.024. Epub 2018 Feb 17.
7
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.降脂治疗与比利时基于风险的 LDL-C 达标情况:DA VINCI 观察性研究。
Acta Cardiol. 2024 Feb;79(1):20-29. doi: 10.1080/00015385.2022.2030568. Epub 2022 Apr 20.
8
How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.欧洲心脏病学会/欧洲动脉粥样硬化学会(ESC/EAS)和2013年美国心脏病学会/美国心脏协会(ACC/AHA)血脂异常治疗指南的效果如何?来自一家血脂诊所的经验教训。
Curr Med Res Opin. 2015 Feb;31(2):221-8. doi: 10.1185/03007995.2014.982751. Epub 2014 Nov 24.
9
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review.根据欧洲指南,欧洲患有低密度脂蛋白胆固醇不达标的高危/极高危患者比例:一项系统性综述。
Adv Ther. 2020 May;37(5):1724-1736. doi: 10.1007/s12325-020-01285-2. Epub 2020 Mar 21.
10
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments.根据 ESC/EAS(2011)指南,在接受调脂治疗的血脂异常风险分层韩国患者中实现 LDL-C 目标。
Endocrinol Metab (Seoul). 2020 Jun;35(2):367-376. doi: 10.3803/EnM.2020.35.2.367. Epub 2020 Jun 24.

引用本文的文献

1
Target Achievements of Low-Density Lipoprotein Cholesterol, Blood Pressure, and Glucose in Patients with Diabetes after Acute Coronary Syndrome: Findings from the Chinese Cardiovascular Association Database - iHeart Project.急性冠状动脉综合征后糖尿病患者低密度脂蛋白胆固醇、血压和血糖的目标达成情况:来自中国心血管病学会数据库-iHeart项目的研究结果
Glob Heart. 2025 Feb 17;20(1):14. doi: 10.5334/gh.1400. eCollection 2025.
2
Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.初级保健中心血管预防面临的挑战:英格兰初级预防中实现生活方式、血压、血脂和糖尿病目标 - ASPIRE-3-PREVENT 横断面调查结果。
Open Heart. 2024 Oct 15;11(2):e002704. doi: 10.1136/openhrt-2024-002704.
3

本文引用的文献

1
Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan.巴基斯坦糖尿病患病率调查(DPS-PAK):使用糖化血红蛋白诊断 2 型糖尿病和糖尿病前期的患病率:来自巴基斯坦的一项基于人群的调查。
BMJ Open. 2019 Feb 21;9(2):e025300. doi: 10.1136/bmjopen-2018-025300.
2
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.27 个国家的冠心病患者生活方式及对心血管危险因素控制的影响:欧洲心脏病学会 ESC-EORP EUROASPIRE V 注册研究结果。
Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.
3
Primary Prevention of Cardiovascular Disease at Community Clinics in the State of Sao Paulo, Brazil: Results from the Epidemiological Information Study of Communities.巴西圣保罗州社区诊所的心血管疾病一级预防:社区流行病学信息研究的结果。
Glob Heart. 2023 May 5;18(1):24. doi: 10.5334/gh.1203. eCollection 2023.
4
Chronic remote ischemic conditioning for symptomatic internal carotid or middle cerebral artery occlusion: A prospective cohort study.慢性远程缺血预处理治疗症状性颈内或大脑中动脉闭塞:一项前瞻性队列研究。
CNS Neurosci Ther. 2022 Sep;28(9):1365-1371. doi: 10.1111/cns.13874. Epub 2022 Jun 15.
5
The Effect of a WeChat-Based Tertiary A-Level Hospital Intervention on Medication Adherence and Risk Factor Control in Patients With Stable Coronary Artery Disease: Multicenter Prospective Study.基于微信的三级甲等医院干预对稳定型冠状动脉疾病患者药物依从性和危险因素控制的影响:多中心前瞻性研究
JMIR Mhealth Uhealth. 2021 Oct 27;9(10):e32548. doi: 10.2196/32548.
6
Risk factor control across the spectrum of cardiovascular risk: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).心血管疾病风险全谱中的危险因素控制:西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)的研究结果
Am J Prev Cardiol. 2021 Jan 13;5:100147. doi: 10.1016/j.ajpc.2021.100147. eCollection 2021 Mar.
7
Targeted Delivery of Salusin-α Into Rabbit Carotid Arterial Endothelium Using SonoVue.超声造影剂 SonoVue 靶向递送 Salusin-α 至兔颈总动脉内皮。
J Ultrasound Med. 2022 Feb;41(2):365-376. doi: 10.1002/jum.15714. Epub 2021 Apr 5.
8
Metabolic control achievement in a population with premature coronary artery disease: results of the genetics of atherosclerotic disease study.早发性冠状动脉疾病人群的代谢控制达标情况:动脉粥样硬化疾病遗传学研究结果
Ther Adv Endocrinol Metab. 2020 Jul 27;11:2042018820943374. doi: 10.1177/2042018820943374. eCollection 2020.
9
Primary Prevention of Cardiovascular Risk in Lithuania-Results from EUROASPIRE V Survey.立陶宛心血管风险的一级预防-EUROASPIRE V 调查结果。
Medicina (Kaunas). 2020 Mar 18;56(3):134. doi: 10.3390/medicina56030134.
10
Hypertension Control Rate Should be Defined Consistently and Used to Motivate Action to Improve.高血压控制率应得到统一界定,并用于激励采取行动加以改善。
High Blood Press Cardiovasc Prev. 2019 Dec;26(6):545-548. doi: 10.1007/s40292-019-00350-4. Epub 2019 Nov 19.
Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey.
巴布亚新几内亚的社会经济地位与行为及心血管风险因素:一项横断面调查。
PLoS One. 2019 Jan 23;14(1):e0211068. doi: 10.1371/journal.pone.0211068. eCollection 2019.
4
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry.美国糖尿病患者复合心血管风险因素目标达标情况及其预测因素:糖尿病协作登记处。
Diabetes Obes Metab. 2019 May;21(5):1121-1127. doi: 10.1111/dom.13625. Epub 2019 Feb 14.
5
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告:2 型糖尿病患者高血糖的管理。
Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5.
6
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
7
A systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countries.非传染性疾病与中低收入国家社会经济地位关系的系统评价。
J Glob Health. 2018 Dec;8(2):020409. doi: 10.7189/jogh.08.020409.
8
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.2 型糖尿病患者的风险因素、死亡率和心血管结局。
N Engl J Med. 2018 Aug 16;379(7):633-644. doi: 10.1056/NEJMoa1800256.
9
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).18 个西欧以外国家的低密度脂蛋白胆固醇目标达标情况:国际胆固醇管理实践研究(ICLPS)。
Eur J Prev Cardiol. 2018 Jul;25(10):1087-1094. doi: 10.1177/2047487318777079. Epub 2018 May 17.
10
Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.中国基层医疗 2 型糖尿病患者多因素治疗靶点及血红蛋白 A1c、血压和低密度脂蛋白胆固醇的相对重要性对心血管疾病的影响:基于人群的回顾性队列研究。
J Am Heart Assoc. 2017 Aug 17;6(8):e006400. doi: 10.1161/JAHA.117.006400.